Overview

Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the role of versican and hyaluronan measurements in induced sputum as biomarkers of asthma. Enroll 10 subjects with mild persistent asthma who are not receiving treatment with a controller therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Associated Scientists to Help Minimize Allergies
Collaborators:
Benaroya Research Institute
GlaxoSmithKline
Treatments:
Fluticasone
Hyaluronic Acid
Xhance